Skip to Content




ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Cytostatic agent

Chemical Name

N-[5-[[(3,4-dihydro-2-metyl-4-oxo-6-quinazolinyl)metyl]metylamino]-2-tenoyl]-L-glutamic acid (WHO)

Foreign Names

  • Raltitrexedum (Latin)
  • Raltitrexed (German)
  • Raltitrexed (French)
  • Raltitrexed (Spanish)

Generic Names

  • Raltitrexed (OS: USAN, BAN, JAN)
  • D 1694 (Zeneca) (IS)
  • ICI-D 1694 (Zeneca) (IS)
  • Paltitrexid (IS)
  • ZD 1694 (Zeneca) (IS)
  • ZN-D 1694 (Zeneca) (IS)

Brand Names

  • Tomudex
    AstraZeneca, Egypt; AstraZeneca, Lebanon; Hospira, Belgium; Hospira, Czech Republic; Hospira, Ireland; Hospira, Malta; Hospira Italia, Italy; Hospira UK, United Kingdom; Orna, Turkey; Pfizer, Australia; Pfizer, Spain; Pfizer, France; Pfizer A/S, Iceland; Zeneca Limited, Lithuania
  • Tomudex 2mg
    Hospira, Austria; Hospira, Hungary; Hospira, Luxembourg; Ospedalia, Switzerland
  • Tomudex
    Pfizer, Canada


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.